Treatment Advances for Pre-Term Labor.
https://reachmd.com/programs/clinicians-roundtable/treatment-advances-for-pre-term-labor/1704/
Almost 13% of all babies in the United Sates are born prematurely. With this growing epidemic, what can be done to prevent and treat pre-term labor and improve newborn outcomes? Our guest today is Dr. Jay Iams who is a nationally recognized expert on pre-term labor. He is the Frederick Zuspan
Updates in SCD: Posters from the 64th ASH Annual Meeting
https://reachmd.com/programs/ash-action-center/updates-in-scd-posters-from-the-64th-ash-annual-meeting/14201/
What's new in the field of sickle cell disease? Get the latest updates from the ASH Poster Walk on What's Hot in Sickle Cell Disease Research 2022.
Cutaneous Signet Ring Squamous Cell Carcinoma: Case Presentation and Brief Literature Review
https://reachmd.com/topics/skin-cancer-photoprotection/cutaneous-signet-ring-squamous-cell-carcinoma-case-presentation-and-brief-literature-review/24026/
An in-depth look at the clinical presentation of this rare tumor type.
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
https://reachmd.com/programs/global-neurology-academy/therapeutic-mechanism-action-moas-ms-targeting-t-and-b-cells-reset-immune-system/9533/
This lecture was given live at Regional Medical Update Dinner on Current and Future Treatments educational program, which was held in select European cities. This highly-interactive live educational meeting will provide attendees with the most recent information concerning new and emerging treatment
Proteomics,Genomics and Everything In Between
https://reachmd.com/programs/clinicians-roundtable/proteomicsgenomics-and-everything-in-between/1597/
Dr. Steve Kron, Associate Professor, Molecular Genetics and Cell Biology at the University of Chicago, and a member of the Committees on Genetics, Cancer Biology, Cell Physiology, and Molecular Medicine discusses proteomics, genomics and everything in between.
Targeted Therapies in Cancer Research
https://reachmd.com/programs/clinicians-roundtable/targeted-therapies-in-cancer-research/1596/
Dr. Steve Kron, Associate Professor, Molecular Genetics and Cell Biology at the University of Chicago, and a member of the Committees on Genetics, Cancer Biology, Cell Physiology, and Molecular Medicine discusses targeted therapies in cancer research.
Life as a Physician Scientist
https://reachmd.com/programs/clinicians-roundtable/life-as-a-physician-scientist/1598/
Dr. Steve Kron, Associate Professor, Molecular Genetics and Cell Biology at the University of Chicago, and a member of the Committees on Genetics, Cancer Biology, Cell Physiology, and Molecular Medicine discusses the life of a physician scientist.
Novel Treatments for Diabetes
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/novel-treatments-for-diabetes/1787/
Dr. Lazar discusses exciting new innovations in our approach to both type I and type II diabetes including Islet cell transplantation, medications for beta cell preservation and new insights into the control of obesity.
Advances in BPDCN Treatment: Targeting Its Pathophysiology
https://reachmd.com/programs/medical-industry-feature/advances-in-bpdcn-treatment-targeting-its-pathophysiology/15991/
Explore the first and only FDA-approved therapy that targets the pathophysiology of blastic plasmacytoid dendritic cell neoplasm in this brief video.
An Approach to Treating BPDCN Patients with Prior or Concomitant Hematologic Malignancies
https://reachmd.com/programs/medical-industry-feature/an-approach-to-treating-bpdcn-patients-with-prior-or-concomitant-hematologic-malignancies/15993/
Learn about the effects of a therapy in patients with blastic plasmacytoid dendritic cell neoplasm and prior or concomitant hematologic malignancies.